Latest News

Alzheimer's prevention trial to monitor reactions to higher disease risk status

A new clinical trial will soon begin testing whether early medical intervention in people at risk for Alzheimer's can slow down progression of disease pathology before symptoms emerge. As part of the overall prevention trial, neurodegenerative ethics experts will monitor how learning about their risk of developing Alzheimer's impacts trial participants.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Sensors used to monitor dangerous hits on football field

  • 'Abandoned' stroke survivors need better longer-term care, expert says

  • Black Republicans put most faith in US government

  • Bedside caregivers: Research shows opening visitation access improves patient satisfaction

  • Expectant mothers with epilepsy face tough choices over their medication

  • Possible cause of common dementia found, opening avenues for treatment

  • Lou Gehrig's disease study: Renewing brain's aging support cells may help neurons survive

  • Minutes in Criminal Procedures: Writing Style Influences Judges

  • Greater inequality within UK, USA than some developing countries, trade 'footprint' shows

  • Even mild depressive symptoms result in poorer lumbar spinal stenosis surgery outcome

  •